HCAL
ASND icon

HURRICANE CAPITAL ADVISORS LLC’s Ascendis Pharma A/S ASND Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46
Closed -$10.5K – 782
2026
Q1 		$10.5K Buy
+46
New +$10.3K ﹤0.01% 611

Other funds holding ASND

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's ASND Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 46 shares — an estimated $10.5K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in ASND in Q1 2026 and held it in 1 quarter. The position peaked at $10.5K in Q1 2026. 315 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 46 Ascendis Pharma A/S shares in Q2 2026, an estimated $10.5K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Ascendis Pharma A/S in Q1 2026 and held it in 1 quarter.
  • HURRICANE CAPITAL ADVISORS LLC's Ascendis Pharma A/S position peaked at $10.5K in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.